awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36858135-6295481D-2BD0-46F8-B0CE-24A7F7DAA9E2
Q36858135-6295481D-2BD0-46F8-B0CE-24A7F7DAA9E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36858135-6295481D-2BD0-46F8-B0CE-24A7F7DAA9E2
Tumour-targeted nanomedicines: principles and practice.
P2860
Q36858135-6295481D-2BD0-46F8-B0CE-24A7F7DAA9E2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36858135-6295481D-2BD0-46F8-B0CE-24A7F7DAA9E2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
baaa0cf103297640511ec4618a111778e84017b7
P2860
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee